Get started
Author

Hamdi I. A. Sati

Observed names: H. I. A. Sati, H. I. Sati, Hamdi Sati
Institution: Singleton Hospital
OpenAlex ID: A5110166967
Pomalidomide, bortezomib, and dexamethasone for patients with relapsed or refractory multiple myeloma previously treated with lenalidomide (OPTIMISMM): a randomised, open-label, phase 3 trial
2019 · Paul G Richardson, Albert Oriol, et al. · The Lancet Oncology · 384
Oral ixazomib maintenance following autologous stem cell transplantation (TOURMALINE-MM3): a double-blind, randomised, placebo-controlled phase 3 trial
2018 · Meletios A Dimopoulos, Francesca Gay, et al. · The Lancet · 237
PDF
Expression of interleukin‐1β and tumour necrosis factor‐α in plasma cells from patients with multiple myeloma
1999 · Hamdi I. A. Sati, Mike Greaves, et al. · British Journal of Haematology · 91
PDF
Pamidronate causes apoptosis of plasma cells in vivo in patients with multiple myeloma
2002 · Sharon Gordon, Miep H. Helfrich, et al. · British Journal of Haematology · 62
Incidence and associations of acute renal failure complicating high‐dose intravenous immunoglobulin therapy
2001 · H. I. A. Sati, R. Ahya, et al. · British Journal of Haematology · 61
PDF
Fludarabine, Cytarabine, Granulocyte Colony-Stimulating Factor, and Idarubicin With Gemtuzumab Ozogamicin Improves Event-Free Survival in Younger Patients With Newly Diagnosed AML and Overall Survival in Patients With NPM1 and FLT3 Mutations
2024 · Nigel H. Russell, Charlotte Wilhelm-Benartzi, et al. · Journal of Clinical Oncology · 49
Patterns of oral anticoagulant use and outcomes in Asian patients with atrial fibrillation: a post-hoc analysis from the GLORIA-AF Registry
2023 · Giulio Francesco Romiti, Bernadette Corica, et al. · EClinicalMedicine · 46
PDF
Interleukin‐6 is expressed by plasma cells from patients with multiple myeloma and monoclonal gammopathy of undetermined significance
1998 · Hamdi I. A. Sati, Jane F. Apperley, et al. · British Journal of Haematology · 46
Comparative effectiveness and safety of non-vitamin K antagonists for atrial fibrillation in clinical practice: GLORIA-AF Registry
2022 · Gregory Y. H. Lip, Agnieszka Kotalczyk, et al. · Clinical Research in Cardiology · 33
PDF
Oral ixazomib-dexamethasone vs oral pomalidomide-dexamethasone for lenalidomide-refractory, proteasome inhibitor-exposed multiple myeloma: a randomized Phase 2 trial
2022 · Meletios A. Dimopoulos, Fredrik Schjesvold, et al. · Blood Cancer Journal · 20
PDF
Ixazomib as consolidation and maintenance versus observation in patients with relapsed multiple myeloma eligible for salvage autologous stem-cell transplantation (Myeloma XII [ACCoRD]): interim analysis of a multicentre, open-label, randomised, phase 3 trial
2024 · Gordon Cook, A John Ashcroft, et al. · The Lancet Haematology · 11
Validating the predictive ability of the 2MACE score for major adverse cardiovascular events in patients with atrial fibrillation: results from phase II/III of the GLORIA-AF registry
2023 · Wern Yew Ding, Ameenathul Mazaya Fawzy, et al. · Journal of Thrombosis and Thrombolysis · 7
Recurrent Adenocarcinoma of Prostate Presenting as Acquired Haemophilia A
1998 · H. I. A. Sati, H. G. Watson · Thrombosis and Haemostasis · 5
Cefotaxime as the potential cause of transient acquired von Willebrand syndrome
2006 · M. A. Haj, N. Murch, et al. · European Journal Of Haematology · 4
Anticoagulant selection in relation to the SAMe-TT2R2 score in patients with atrial fibrillation: The GLORIA-AF registry
2020 · George Ntaios, Menno V. Huisman, et al. · Hellenic Journal of Cardiology · 3
PDF
Oral ixazomib-dexamethasone versus oral pomalidomide-dexamethasone for lenalidomide-refractory, proteasome inhibitor-exposed multiple myeloma (MM) patients: A global, multicenter, randomized, open-label, phase 2 trial.
2021 · Meletios A. Dimopoulos, Fredrik Schjesvold, et al. · Journal of Clinical Oncology · 2
OA-59 Proteasome Inhibitor-Augmented Salvage Autologous Stem Cell Transplantation for First Relapse Management in Relapsed Multiple Myeloma
2024 · Christopher Parrish, Alexandra Welsh, et al. · Clinical Lymphoma Myeloma & Leukemia
Ixazomib-Based Consolidation and Maintenance Prolongs Progression-Free Survival after Salvage Autologous Stem Cell Transplantation (sASCT): Results from Interim Analysis of UK-MRA Myeloma XII (ACCoRD)
2023 · Gordon Cook, A J Ashcroft, et al. · Blood
PDF
Correction to: Comparative effectiveness and safety of non-vitamin K antagonists for atrial fibrillation in clinical practice: GLORIA-AF Registry
2022 · Gregory Y. H. Lip, Agnieszka Kotalczyk, et al. · Clinical Research in Cardiology
PDF
Works count: 19
Citation count: 1,060
H-index: 11
I10-index: 11
Year
Topic
Type